Venture capital investment in global healthtech companies is projected to reach $42 billion by the end of the year, according to Silicon Valley Bank's latest report, "The Future of HealthTech."
The first three quarters of 2021 closed with what SVB called an astounding $34 billion invested globally across 1,040 deals.
